when do compounding pharmacies have to stop selling tirzepatide Compounded Tirzepatide: Legal & Safe 2026 Compounding pharmacies can resume making

Suzuki K, Okada H, Takemura G, Takada C, Tomita H, Yano H, Muraki I, Zaikokuji R, Kuroda A, Fukuda H, Nishio A, Takashima S, Suzuki A, Miyazaki N, Fukuta T, Yamada N, Watanabe T, Doi T, Yoshida T, Kumada K, Ushikoshi H, Yoshida S, Ogura S

Key Phase 2 Findings In a randomized study of 65 patients with obesity or overweight with comorbidities, patients received ASC30 monthly for three months

The topline SURPASSCVOT results were first released in a corporate communication, and this subsequent peerreviewed New England Journal of Medicine publication from December 2025 provided the full randomized, doubleblind, eventdriven dataset, including detailed cardiovascular, renal, and safety outcomes monitored for a median of 4 years

Jennifer, a 52-year-old attorney, was losing cognitive endurance during long, complex cases

Activated JNK phosphorylates and inhibits the activity of the anti-apoptotic protein Bcl-2, while simultaneously promoting the oligomerization of the pro-apoptotic protein Bax on the mitochondrial membrane

Currently, weight loss surgery stands out as the most effective approach to address obesity